Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 TLR-10 polymorphism and papillary thyroid cancer: one more SNP to consider?

Literature DB >> 23138464

TLR-10 polymorphism and papillary thyroid cancer: one more SNP to consider?

Myriem Boufraqech, Catsim Fassassi, Electron Kebebew.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2012 PMID： 23138464 DOI： 10.1007/s12020-012-9827-4

Source DB: PubMed Journal: Endocrine ISSN： 1355-008X Impact factor: 3.633

× No keyword cloud information.

14 in total

1. Proinflammatory mediators and genetic background in oncogene mediated tumor progression.

Authors: John P Russell; Julie B Engiles; Jay L Rothstein
Journal: J Immunol Date: 2004-04-01 Impact factor: 5.422

2. Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.

Authors: Salomé González-Reyes; Jesús M Fernández; Luis O González; Alina Aguirre; Aurelio Suárez; José M González; Safwan Escaff; Francisco J Vizoso
Journal: Cancer Immunol Immunother Date: 2010-10-27 Impact factor: 6.968

3. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.

Authors: B Belletti; P Ferraro; C Arra; G Baldassarre; P Bruni; S Staibano; G De Rosa; G Salvatore; A Fusco; M G Persico; G Viglietto
Journal: Oncogene Date: 1999-08-26 Impact factor: 9.867

4. Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia.

Authors: Pedro Pimentel-Nunes; Luís Afonso; Paula Lopes; Roberto Roncon-Albuquerque; Nádia Gonçalves; Rui Henrique; Luís Moreira-Dias; Adelino F Leite-Moreira; Mário Dinis-Ribeiro
Journal: Pathol Oncol Res Date: 2011-04-01 Impact factor: 3.201

5. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.

Authors: Su Kang Kim; Hae Jeong Park; Il Ki Hong; Joo-Ho Chung; Young Gyu Eun
Journal: Endocrine Date: 2012-11-03 Impact factor: 3.633

TLR-10 polymorphism and papillary thyroid cancer: one more SNP to consider?

1. Proinflammatory mediators and genetic background in oncogene mediated tumor progression.

2. Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.

3. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.

4. Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia.

5. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.

6. The Relationship of Lymphocytic Thyroiditis to the Development of Thyroid Carcinoma.

7. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.

8. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.

9. The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells.

10. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.

1. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.